May. 7 at 12:24 PM
$BDX
🚨🚨🚨
Becton, Dickinson and Company reported fiscal second-quarter 2026 revenue of
$4.7 billion, up 5.2% year over year, driven by mid‑single‑digit growth across most businesses.
U.S. revenue rose to
$2.9 billion and international revenue to
$1.8 billion.
From continuing operations, BD posted a GAAP diluted loss per share of $(0.13) versus earnings of
$0.55 a year ago, reflecting higher integration, restructuring and other specified charges and the impact of discontinued operations.
On an adjusted basis, diluted EPS from continuing operations was
$2.90, up from
$2.79.
BD executed a
$2.0 billion accelerated share repurchase program and retired
$2.1 billion of debt during the quarter.
After completing the spin-off of its Biosciences and Diagnostic Solutions business, BD reaffirmed its full‑year 2026 revenue growth outlook and raised its adjusted diluted EPS guidance to a range of
$12.52 to
$12.72.
